miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines (Q33530333)

27 July 2017

title

miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines (English)

1 reference

27 July 2017

1 reference

1 reference

Jingyi Gu

1

1 reference

27 July 2017

Xuejiao Zhu

2

1 reference

27 July 2017

Yumin Li

3

1 reference

27 July 2017

Dawei Dong

4

1 reference

27 July 2017

Junlin Yao

5

1 reference

27 July 2017

Chunyan Lin

6

1 reference

27 July 2017

Kangkang Huang

7

1 reference

27 July 2017

Haiyan Hu

8

1 reference

27 July 2017

Jia Fei

9

1 reference

27 July 2017

publication date

9 February 2010

1 reference

27 July 2017

1 reference

27 July 2017

volume

28

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

211-218

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

miRBase: microRNA sequences, targets and gene nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

The functions of animal microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

MicroRNAs modulate the chemosensitivity of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Combined effects of As4S4 and imatinib on chronic myeloid leukemia cells and BCR-ABL oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Expanding the use of arsenic trioxide: leukemias and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Prediction of mammalian microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Oncomirs: the potential role of non-coding microRNAs in understanding cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Inhibition of microRNA with antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

MicroRNA-directed cleavage of HOXB8 mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Ago-TNRC6 triggers microRNA-mediated decay by promoting two deadenylation steps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

miR-21: a small multi-faceted RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

miR-21 as a key regulator of oncogenic processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9413-7

Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients

21 January 2018

1 reference

12 December 2020

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

1 reference

12 December 2020

Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity

1 reference

12 December 2020

Arsenic and old myths.

1 reference

12 December 2020

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients

1 reference

12 December 2020

p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells.

1 reference

12 December 2020

Global analysis of microRNA target gene expression reveals that miRNA targets are lower expressed in mature mouse and Drosophila tissues than in the embryos

1 reference

12 December 2020

10.1007/S12032-009-9413-7

Identifiers

DOI

1 reference

Dimensions Publication ID

27 July 2017

1034065046

0 references

Fatcat ID

release_sgnhpz6ccfbh3hzwmsa7lfuozi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sgnhpz6ccfbh3hzwmsa7lfuozi

24 November 2022

mapped directly with Wikidata item

1 reference